Comparison of immune responses to Brucella melitensis Rev.1 conjunctival or subcutaneous vaccinations in sexually immature endangered scimitar-horned oryx (Oryx dammah)

Authors

  • Louis Lignereux Faculty of Veterinary Medicine, Research Unit in Epidemiology and Risk Analysis Applied to Veterinary Sciences (UREAR-ULiège), Fundamental and Applied Research for Animals and Health (FARAH) Center, University of Liège, Liège, Belgium https://orcid.org/0000-0001-6493-9226
  • Maria Elena Pesci Terrestrial Biodiversity, Environment Agency- Abu Dhabi, Abu Dhabi, United Arab Emirates
  • Claude Saegerman Faculty of Veterinary Medicine, Research Unit in Epidemiology and Risk Analysis Applied to Veterinary Sciences (UREAR-ULiège), Fundamental and Applied Research for Animals and Health (FARAH) Center, University of Liège, Liège, Belgium https://orcid.org/0000-0001-9087-7436

DOI:

https://doi.org/10.12834/VetIt.3687.32568.2

Keywords:

allergic test, conservation, immune response, prevention, randomised controlled trial, serology, wildlife

Abstract

A single dose of 1-2 x 109 CFU of the Brucella melitensis Rev.1 vaccine strain was administered subcutaneously or conjunctivally to two groups of ten sexually immature scimitar-horned oryx (SHO). A third group of ten served as unvaccinated controls. These groups were housed together and bred, producing offspring. No clinical signs appeared during the week following administration. The rose Bengal test (RBT), a lateral flow assay (LFA), and the brucellin skin test (BST) were conducted before and during the experiment to assess humoral and cellular immune responses. These responses were rapid and strong. The cellular response was durable and similar in both groups, with 80% of vaccinated SHO still positive 184 weeks post-vaccination (PV). The conjunctival route resulted in a shorter serological response, with all animals RBT seronegative at 12 weeks PV, compared to 57% still positive at 74 weeks PV with the subcutaneous route. LFA positivity remained high in both groups until 30 weeks PV, then decreased faster in the conjunctival group. All SHO returned to LFA negativity by 74 weeks PV. No reactions to RBT and BST were observed in the control group or offspring. These findings offer a strategic approach for managing brucellosis outbreaks in captive SHO.

References

Benkirane, A. (2001). Surveillance épidémiologique et prophylaxie de la brucellose des ruminants: L’exemple de la région Afrique du Nord et Proche-Orient. Revue Scientifique et Technique de l’OIE (France), 20(3). https://doi.org/10.20506/rst.20.3.1314.

Blasco, J.M., 2010. Control and eradication strategies for Brucella melitensis infection in sheep and goats. Prilozi 31, 145–165.

Brinley Morgan, W.J., Littlejohn, A.I., Mackinnon, D.J., Lawson, J.R., 1966. The degree of protection given by living vaccines against experimental infection with Brucella melitensis in goats. Bull. World Health Organ. 34, 33–40.

Environment Agency Abu Dhabi, 2016. Technical guidance document for scientific research permitting in Abu Dhabi Emirate [WWW Document]. URL https://www.ead.gov.ae/-/media/Project/EAD/EAD/Documents/ResearchHub/Research-Project-Technical-Guidance-Document.pdf (accessed 6.14.23).

Fensterbank, R., Doutre, M.P., Sagna, F., 1977. Étude de la brucellose bovine dans un village de Basse-Casamance (Sénégal). II. Diagnostic allergique. Rev. D’élevage Médecine Vét. Pays Trop. 30, 353–358. https://doi.org/10.19182/remvt.8072.

Fensterbank, R., Pardon, P., Marly, J., 1985. Vaccination of ewes by a single conjunctival administration of Brucella melitensis Rev. 1 vaccine. Ann. Rech. Vét. 16, 351–356.

Fensterbank, R., Pardon, P., Marly, J., 1982. Comparison between subcutaneous and conjunctival route of vaccination with Rev. 1 strain against Brucella melitensis infection in ewes. Ann. Rech. Vét. 13, 295–301.

Fensterbank, R., Verger, J.M., Grayon, M., 1987. Conjunctival vaccination of young goats with Brucella melitensis strain Rev 1. Ann. Rech. Vét. 18, 397–403.

Godfroid, J., Garin-Bastuji, B., Saegerman, C., Blasco, J.M., 2013. Brucellosis in terrestrial wildlife. Rev. Sci. Tech. OIE 32, 27–42. https://doi.org/10.20506/rst.32.1.2180.

Godfroid, J., Nielsen, K., Saegerman, C., 2010. Diagnosis of brucellosis in livestock and wildlife. Croat. Med. J. 51, 296–305. http://dx.doi.org/10.3325/cmj.2010.51.296.

Jiménez, de B.M., Marin, C.M., Barberán, M., Blasco, J.M., 1989. Responses of ewes to B. melitensis Rev1 vaccine administered by subcutaneous or conjunctival routes at different stages of pregnancy. Ann. Rech. Veterinaires Ann. Vet. Res. 20, 205–213.

Kurmanov, B., Zincke, D., Su, W., Hadfield, T.L., Aikimbayev, A., Karibayev, T., Berdikulov, M., Orynbayev, M., Nikolich, M.P., Blackburn, J.K., 2022. Assays for identification and differentiation of Brucella species: a review. Microorganisms 10, 1584. https://doi.org/10.3390/microorganisms10081584.

Lee, S., Lee, D.K., 2018. What is the proper way to apply the multiple comparison test? Korean J. Anesthesiol. 71, 353–360. https://doi.org/10.4097/kja.d.18.00242.

Lignereux, L., Chaber, A.-L., Fretin, D., Godfroid, J., Saegerman, C., 2022a. Brucella melitensis biovar 1 isolation in a captive wildlife population in the United Arab Emirates. First isolation in the scimitar-horned Oryx (Oryx dammah). Vet. Microbiol. 266, 109360. https://doi.org/10.1016/j.vetmic.2022.109360.

Lignereux, L., Chaber, A.-L., Nemery, Q., Godfroid, J., Saegerman, C., 2022b. Brucellosis seroprevalence in captive scimitar-horned oryx (Oryx dammah) in the United Arab Emirates and associated risk factors. Emerg. Anim. Species 5, 100016. https://doi.org/10.1016/j.eas.2022.100016.

Milward, F.W., 1995. Production and quality control of vaccines for brucellosis with a specific emphasis on Rev1 vaccine, in: FAO/WHO/OIE Round Table on the Use of Rev.1 Vaccine in Small Ruminants and Cattle. CNEVA - Alfort, France, CNEVA - Alfort, France, pp. 53–60.

Pardon, P., Sanchis, R., Molenat, G., Bouchard, N., Schmitt, D., Marly, J., Durand, M., 1989. Persistance des réactions sérologiques et allergiques consécutives à la vaccination par les vaccins H.38 ou Rev.1 de brebis en zone d’enzootie brucellique (Brucella melitensis). Ann. Rech. Vét. 20, 65.

Ponsart, C., Riou, M., Locatelli, Y., Jacques, I., Fadeau, A., Jay, M., Simon, R., Perrot, L., Freddi, L., Breton, S., Chaumeil, T., Blanc, B., Ortiz, K., Vion, C., Rioult, D., Quéméré, E., Sarradin, P., Chollet, J.-Y., Garin-Bastuji, B., Rossi, S., 2019. Brucella melitensis Rev.1 vaccination generates a higher shedding risk of the vaccine strain in Alpine ibex (Capra ibex) compared to the domestic goat (Capra hircus). Vet. Res. 50, 100. https://doi.org/10.1186/s13567-019-0717-0.

Saegerman, C., Vo, T.-K.O., Waele, L.D., Gilson, D., Bastin, A., Dubray, G., Flanagan, P., Limet, J.N., Letesson, J.-J., Godfroid, J., 1999. Diagnosis of bovine brucellosis by skin test: conditions for the test and evaluation of its performance. Vet. Rec. 145, 214–218. https://doi.org/10.1136/vr.145.8.214.

WOAH, 2022. Manual of diagnostic tests and vaccines for terrestrial animals 2022. Chap 3.1.4 Brucellosis (infection with Brucella abortus, B.melitensis and B. suis).

Young, E.J., 1995. An overview of human brucellosis. Clin. Infect. Dis. 21, 283–290. https://doi.org/10.1093/clinids/21.2.283.

Zundel, E., Verger, J., Grayon, M., Michel, R., 1992. Conjunctival vaccination of pregnant ewes and goats with Brucella melitensis Rev 1 vaccine: safety and serological responses. Ann. Rech. Vét. 23, 177–188.

Downloads

Published

2024-09-30

How to Cite

Lignereux, L., Pesci, M. E., & Saegerman, C. . (2024). Comparison of immune responses to Brucella melitensis Rev.1 conjunctival or subcutaneous vaccinations in sexually immature endangered scimitar-horned oryx (Oryx dammah). Veterinaria Italiana, 60(3). https://doi.org/10.12834/VetIt.3687.32568.2

Issue

Section

Special Issue Brucellosis

Similar Articles

<< < 7 8 9 10 11 12 

You may also start an advanced similarity search for this article.